✦ LIBER ✦

Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys

✍ Scribed by Michael S. Ominsky; Brian Stouch; Joseph Schroeder; Ian Pyrah; Marina Stolina; Susan Y. Smith; Paul J. Kostenuik

Book ID: 116324883
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 773 KB
Volume: 49
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2011.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased bone remodeling and porosity a

Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody

✍ Paul J. Kostenuik; Susan Y. Smith; Jacquelin Jolette; Joseph Schroeder; Ian Pyra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 1010 KB

Further reductions in bone turnover afte

Further reductions in bone turnover after transition from alendronate to denosumab in ovariectomized cynomolgus monkeys resulted in maintained or improved cortical and trabecular bone mass and bone strength

✍ M.S. Ominsky; S.Y. Smith; J. Jolette; F. Vlasseros; R. Samadfam; P.J. Kostenuik 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Intermittently Administered Human Parath

Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys

✍ David B. Burr; Toru Hirano; Charles H. Turner; Charlotte Hotchkiss; Robert Bromm 📂 Article 📅 2001 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 323 KB